Infection, Transmission, Pathogenesis and Vaccine Development against Mycoplasma gallisepticum

Area of Science:

• Veterinary Microbiology
• Avian Pathology
• Bacterial Pathogenesis

Background:

• Mycoplasma gallisepticum (MG) is a significant avian pathogen causing respiratory, reproductive, and musculoskeletal issues in poultry.
• MG is a cell-wall-less bacterium with a reduced genome, known for its wide host susceptibility and virulence.
• Transmission occurs through both horizontal and vertical routes, necessitating robust control strategies.

Purpose of the Study:

• To review the pathogenic mechanisms of Mycoplasma gallisepticum (MG) infection in avian species.
• To summarize the key virulence factors involved in MG pathogenesis, including host cell adhesion and immune evasion.
• To highlight current limitations in MG vaccines and explore avenues for innovative vaccine development.

Main Methods:

• Literature review summarizing existing research on Mycoplasma gallisepticum.
• Analysis of pathogenic mechanisms, including bacterial virulence factors and host immune responses.
• Evaluation of current prevention and control strategies, including vaccination.

Main Results:

• MG infection triggers complex innate, cellular, mucosal, and adaptive immune responses involving macrophages, B cells, and T cells.
• Key virulence factors include adhesion proteins, lipoproteins, heat shock proteins, and antigenic variation proteins, facilitating host cell entry and pathogenesis.
• Effective prevention requires integrated biosecurity, management, diagnostics, antimicrobials, and vaccination.

Conclusions:

• A comprehensive understanding of MG virulence factors is crucial for combating avian mycoplasmosis.
• Current vaccines have limitations, underscoring the need for novel vaccine strategies against MG.
• Future research should focus on developing innovative vaccines that target key virulence mechanisms for improved efficacy.